Internal Medicine, Medical Oncology · Houston, TX
NPI
1073979035
Since 2016
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
439 services
Medicare patients, 2024
174
Average age 73
Drug cost, 2024
$1.9M
230 prescriptions
Company payments, 2025
$6,782
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yasir Elamin was code 99214 (office e&m - established), 204 times for 107 patients. In total Yasir Elamin billed 439 services in 11 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 204 | 107 | $70.89 | $14K |
| 99215 Office E&M - Established | Facility | 125 | 53 | $105.59 | $13K |
| 99205 Office E&M - New | Facility | 40 | 40 | $136.13 | $5,445 |
| 99214 Office E&M - Established | Office | 20 | 16 | $95.21 | $1,904 |
By year: 2022 $63K for 630 services; 2023 $49K for 488 services; 2024 $39K for 439 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yasir Elamin prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 70 prescriptions and refills. In total Yasir Elamin wrote 230 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 70 | 80 | Under 11 | $1.3M |
| Dexamethasone Generic | 31 | 31 | 17 | $311 |
| Ondansetron Hcl Generic | 27 | 27 | 20 | $690 |
| Erlotinib Hcl Generic | 18 | 26 | Under 11 | $84K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 15 | 17 | Under 11 | $221 |
| Alecensa Alectinib Hcl | 12 | 12 | Under 11 | $209K |
Brand drugs: 100 claims; generic drugs: 130 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yasir Elamin $6,782 ($6,782 in general payments such as food, travel and fees) from 6 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $3,146.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.